Conference call interim report Invitation to attend Vitrolife's conference call regarding presentation of the interim report for the period January-March 2007. The presentation will be held in Swedish. Time: Friday, May 4, 2007 at 11 a.m. CET. Telephone number: +46 8 505 201 10 Conference name: Vitrolife Vitrolife participants: Magnus Nilsson, CEO Anna Ahlberg, CFO The press release for Vitrolife's interim report for the period January-March 2007 will be released on Thursday, May 3. Before the conference call, slides will be available at the company web page, www.vitrolife.com, under the section Investors/News (the Swedish page). A recorded version of the presentation will be available for seven days on number +46 8 505 203 33, access code 748069. Queries should be addressed to: Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13. ________________________________________________________________________________ _________ Vitrolife is a global biotechnology/medical device Group that works with developing, manufacturing and selling advanced products and systems for the preparation, cultivation and storage of human cells, tissue and organs. The company has business activities within three product areas: Fertility, Transplantation and Stem Cell Cultivation. The Fertility product area works with nutrient solutions (media) and advanced one-time instruments such as needles and pipettes, for the treatment of human infertility. The Transplantation product area works with solutions and systems to maintain tissue in optimal condition outside the body for the required time while waiting for transplantation. The Stem Cell Cultivation product area works with media and instruments to enable the use and handling of stem cells for therapeutic purposes. Vitrolife today has approximately 120 employees and the company's products are sold in more than 80 markets. The head office is in Kungsbacka, Sweden, and there are subsidiaries outside Gothenburg, Sweden and in Denver, USA. The Vitrolife share is listed on the Stockholm Stock Exchange's Nordic Small Cap list. ________________________________________________________________________________ _________ Vitrolife AB (publ), Faktorvägen 13, SE-434 37 Kungsbacka, Sweden. Corporate identity number 556354-3452. Tel: +46 31 721 80 00. Fax: +46 31 721 80 90. E-mail: info@vitrolife.com. Homepage: www.vitrolife.com.
Conference call interim report
| Source: Vitrolife AB